Nexus AG
Ad hoc-Service: Nexus AG english
Ad hoc-announcement edited and send by DGAP.
The sender is responsible for the contents of this announcement.
——————————————————————————
Massive growth of the NEXUS Group
Villingen-Schwenningen, 28.08.2000 – NEXUS AG, a group of companies
offering IT solutions for the health industry that has been quoted on
the Neuer Markt exchange since 24th July of this year, managed to
extend its business activities enormously and to boost its rate of
expansion during the first half of the year 2000. The group’s turnover
increased in comparison with the same period of last year by 183
percent to DM 28.3 million. This growth is attributable to, among other
things, the growing demand for the software products Med-Folio, an
electronic system of recording patient data, and INO-RMS, a radiology
management system, as well as to a number of company share purchases.
The group’s results developed according to plan. Because of the very
large resources invested in the development and marketing of software
products (approx. DM 3.8 million), the building of a dense service
network (approx. DM 4.1 million) and the creation of the Internet
platform Medizin-Forum-AG (approx. DM 800,000), NEXUS showed a deficit
according to IAS of DM 4.2 million for the group as a whole. In the
same period of the previous year, the deficit amounted to only DM 1.7
million. The result of the group’s ordinary business activity was a
minus of DM 6.9 million as compared with a loss of DM 3.3 million in
the first six months of 1999. The costs of the group’s admission to the
stock market are not included in these figures.
At 30th June 2000 NEXUS was employing a staff of 406. One year ago its
employees totalled only 106.
During the second half of the year 2000 NEXUS intends to concentrate on
increasing its earnings potential and on rounding out its product and
company-share portfolios. The group hopes at the same time to maintain
the strong growth that it has shown up to now. It plans, for example,
to internationalize its business activities still further. In this
connection, among other things, it is hoping to reap considerable
benefits from the cooperation agreement concluded in the first half of
this year with the world’s leading oncological specialists, MDS
Nordion, through which NEXUS has been able to secure access to a global
marketing channel in this sector.
Additional information can be obtained from:
NEXUS AG
Carmen Stangl
Tel.: 077 21 / 84 82 44
Fax: 077 21 / 84 82 99
E-mail: carmen.stangl@nexus-ag.de
End of Message
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden